Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Swanson

Showing results (371-380 of 433) with videos related to

Pageof 44
Sort By:
JAMA|May 12, 1978
Cooperative study of hospital frequency and character of transient ischemic attacksR A Gotshall, T R Price, A F Haerer, et al.
Neurology|May 29, 2001
Parkinson's disease, CYP2D6 polymorphism, and ageH Payami, N Lee, S Zareparsi, et al.
Nature Chemical Biology|June 28, 2011
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleAndrew C Stelzer, Aaron T Frank, Jeremy D Kratz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Genetic polymorphisms of superoxide dismutase in Parkinson's diseaseF M Farin, Y Hitosis, S E Hallagan, et al.
Biosensors & Bioelectronics|April 18, 2002
An integrated, stacked microlaboratory for biological agent detection with DNA and immunoassaysJoon Mo Yang, Janice Bell, Ying Huang, et al.
Nature Communications|April 24, 2025
DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosisDa Teng, Kenneth D Swanson, Ruiheng Wang, et al.
JAMA|August 25, 1978
Cooperative study of hospital frequency and character of transient ischemic attacks. VIII. Risk factorsP M Conneally, M L Dyken, D E Futty, et al.
Journal of Clinical Medicine|May 14, 2022
Molecular Classes and Growth Hormone Treatment Effects on Behavior and Emotion in Patients with Prader-Willi SyndromeRanim Mahmoud, Heidi D Swanson, Merlin G Butler, et al.
Cell|January 15, 1993
DNA deletion associated with hereditary neuropathy with liability to pressure palsiesP F Chance, M K Alderson, K A Leppig, et al.
Pharmacogenetics and Genomics|July 26, 2005
Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's diseaseSamir N Kelada, Paola Costa-Mallen, Harvey Checkoway, et al.
Pageof 44

Showing results (371-380 of 433) with videos related to

Sort By:
Pageof 44
JAMA|May 12, 1978
Cooperative study of hospital frequency and character of transient ischemic attacksR A Gotshall, T R Price, A F Haerer, et al.
Neurology|May 29, 2001
Parkinson's disease, CYP2D6 polymorphism, and ageH Payami, N Lee, S Zareparsi, et al.
Nature Chemical Biology|June 28, 2011
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleAndrew C Stelzer, Aaron T Frank, Jeremy D Kratz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Genetic polymorphisms of superoxide dismutase in Parkinson's diseaseF M Farin, Y Hitosis, S E Hallagan, et al.
Biosensors & Bioelectronics|April 18, 2002
An integrated, stacked microlaboratory for biological agent detection with DNA and immunoassaysJoon Mo Yang, Janice Bell, Ying Huang, et al.
Nature Communications|April 24, 2025
DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosisDa Teng, Kenneth D Swanson, Ruiheng Wang, et al.
JAMA|August 25, 1978
Cooperative study of hospital frequency and character of transient ischemic attacks. VIII. Risk factorsP M Conneally, M L Dyken, D E Futty, et al.
Journal of Clinical Medicine|May 14, 2022
Molecular Classes and Growth Hormone Treatment Effects on Behavior and Emotion in Patients with Prader-Willi SyndromeRanim Mahmoud, Heidi D Swanson, Merlin G Butler, et al.
Cell|January 15, 1993
DNA deletion associated with hereditary neuropathy with liability to pressure palsiesP F Chance, M K Alderson, K A Leppig, et al.
Pharmacogenetics and Genomics|July 26, 2005
Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's diseaseSamir N Kelada, Paola Costa-Mallen, Harvey Checkoway, et al.
Pageof 44